Hyatt Hotels Q2 Adjusted Earnings Fall, Revenue Rises-March 2024-www.financetom.com

Hyatt Hotels Q2 Adjusted Earnings Fall, Revenue Rises

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Hyatt Hotels Q2 Adjusted Earnings Fall, Revenue Rises

Aug 7, 2025 4:58 AM

07:40 AM EDT, 08/07/2025 (MT Newswires) -- Hyatt Hotels ( H ) reported Q2 adjusted earnings Thursday of $0.68 per diluted share, down from $1.53 a year earlier.

Analysts polled by FactSet expected $0.64.

Total revenue for the quarter ended June 30 was $1.81 billion, compared with $1.70 billion a year earlier.

Analysts surveyed by FactSet expected $1.74 billion.

Previous page： FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves Next page： Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves

Oct 17, 2024

Novavax Inc. ( NVAX ) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates. The clinical hold is due to a spontaneous report of a serious adverse event (SAE) of motor neuropathy in a single CIC Phase 2 trial participant outside...

Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall

Oct 17, 2024

09:18 AM EDT, 10/16/2024 (MT Newswires) -- Novavax ( NVAX ) said Wednesday that the US Food and Drug Administration has placed a clinical hold on its investigational new drug application for its COVID-19-influenza combination and standalone influenza vaccine candidates. The company said the clinical hold is due to a report of a serious adverse event involving motor neuropathy in...

ASML's early earnings publication a 'human mistake', shareholder group says

Oct 17, 2024

AMSTERDAM (Reuters) - A group of Dutch shareholders on Wednesday reacted with dismay to chip equipment maker's ASML's accidental early publication of its third-quarter earnings, but were also sympathetic to what they called a human mistake. For a company which is the largest listed company in the Netherlands and also the leading technology company in Europe ... it is not...

Prologis raises full-year forecast, cites stabilizing demand

Oct 17, 2024

Oct 16 (Reuters) - Real estate investment trust (REIT) Prologis ( PLD ) raised the lower end of its full-year forecast for adjusted core funds from operations on Wednesday due to strong long-term demand drivers, sending its shares up 1.5% in premarket. The warehouse-focused REIT said the decline in business activity, which began after a downturn in freight demand post...